Some patients with intracranial
A rticle abstract-A reduced production of type III collagen has been reported in previous studies to be associated with intracranial aneurysms. The purpose of this prospective case-control study was to assess the possible role of a reduced type III collagen production as a risk factor for having an intracranial aneurysm. The study group consisted of 41 consecutively admitted patients with intracranial aneurysms. Intracranial aneurysms were demonstrated by intraarterial digital subtraction cerebral angiography or during operation. The control group consisted of 41 healthy volunteers matched for age and sex. Fibroblasts were cultured from skin biopsies from patients and control subjects, and the type Ill/type I collagen ratios were determined. The type Ill/type I collagen ratios in the controls ranged from 5.5 to 19.8%, with a median ratio of 10%, and none had a ratio below 5.5%. The type Ill/type I collagen ratios in patients ranged from 1.1 to 25.1%, with a median ratio of 10.5%, and eight patients (19,5%) had a low (<5.5%) ratio (p = 0.005, Fisher's exact test).
Our findings support the hypothesis that a reduced production of type III collagen may contribute to the formation of intracranial aneurysms in some patients. NEUROLOGY 1997; 49:1546 -1551 Subarachnoid hemorrhages represent approximately 7% of all strokes1 and account for 45% of the strokes between the ages of 35 and 44 years.2 Over the last four decades, the incidence of subarachnoid hemor rhages has not changed, and the mortality rate has remained high.1» 3 Many survivors remain in a dis abled state.1 Most subarachnoid hemorrhages are caused by rupture of an intracranial aneurysm.4 Early detection and preventive surgery may lead to an increased lifespan.5 Mortality and morbidity for surgery of unruptured intracranial aneurysms are relatively low.6 Understanding of the underlying mechanisms leading to the formation of intracranial aneurysms is important in view of the development of preventive strategies. One hypothesis considers the pathogenesis of in tracranial aneurysms to be a multifactorial process in which both intrinsic factors, such as vessel wall abnormalities, and extrinsic factors, such as hyper tension, play a role.7'9 A reduced production of type III collagen is a possible candidate for such an intrin sic factor. Several observations suggest a relation ship between a defect of type III collagen and the pathogenesis of intracranial aneurysms. Type III col lagen is responsible for the tensile strength of the arteries, especially when the strain on the vessel wall becomes high.10-12 Mutations in the type I I I col lagen gene, encoding the type I I I procollagen, pro duces the Ehlers-Danlos type IV phenotype.13 Ehlers-Danlos type IV patients show a diversity of clinical symptoms, including skin laxity and rup tured intracranial aneurysms.14'15
Several protein-based studies have revealed a re lationship between a reduced production of type III collagen and intracranial aneurysms.16-21 However, Kuivaniemi et al.,22 using DNA sequence analysis of part of the gene encoding the triple-helical domain of type III collagen in 40 patients with intracranial an eurysms, did not observe mutations and concluded that structural mutations in the gene encoding for type I I I collagen are not a common cause of intracra nial aneurysms.
To investigate a possible significance of a reduced production of type I I I collagen on the protein level, we determined the type Ill/type I collagen ratios from skin fibroblasts of patients with intracranial aneurysms and compared these with type Ill/type I collagen ratios in control subjects. Our study ques-M ethods. In a prospective study, we included all consecu tive patients with an intracranial aneurysm admitted to the Department of Neurosurgery of the Academic Medical Center in Amsterdam. The diagnosis had to be con-firmed by a threevessel intra-arterial digital subtraction angiography or at craniotomy. Hypertension, polycystic kidney disease, or other renal abnormalities; symptoms fitting Marfan syndrome; Ehlers-Danlos syndrome type IV; pseudoxanthoma elasticum; and family history of the same factors were recorded from the medical history. Patients were examined by two experienced clinical geneticists (R.C.M.H. and the late J.W. Oorthuys) for signs of Ehlers-Danlos syndrome type IV, Marfan syndrome, and pseudoxanthoma elasticum. The cere bral angiograms were independently studied by two investi gators who scored the localization and size of the aneurysm. The largest measured diameter in any projection was taken as the size of the aneurysm. In case of any discrepancy, the angiograms were discussed, and a consensus between the two observers was obtained. The control group consisted of 41 healthy volunteers (personnel from the Academic. Medical Center) matched for age and gender and without a history of intracranial aneurysms. The study was approved by the Hospital Medical Ethical Committee.
Biochemical and molecular studies. After informed consent, a skin biopsy was taken for fibroblast culture. Fibroblasts were cultured to confluence in 25 cm2 flasks in Ham's F10 (Life Technologies, Bethesda, MD) with 10% fetal calf serum. Metabolic labeling was performed for 20 hours in 2 mL BME prolin free media (Life Technologies) containing 5% dialyzed fetal calf serum, 37 jxg/mL Lascorbic acid, 2 fxCi/ml L-[U14C]-Prolin (Amersham Inter national, Little Chalton, U.K.). After ethanol precipitation of 333-fiL aliquots of media, the pellets were dissolved in 150 |xL 0.5 M acetic acid. One aliquot of each sample was treated with pepsin for the analysis of collagen; untreated aliquots were used for procollagen. The cells were trypsinized, centrifuged, washed, and frozen as dry pellets. The pellets were homogenized in 150 jjl L 0.5 M acetic acid. After centrifugation, the supernatants were used for elec trophoresis. After liquid scintillation counting, 20,000 cpm aliquots of the samples (between 5 and 10 \lL) were lyophilized, dissolved in 20 |jiL of sample loading buffer (Promega Corp., Madison, WI), and subjected to SDS-PAGE in a Protean II electrophoresis system (Bio-Rad, Hercules, CA). After 90 minutes at 200 V (10°C), the samples were reduced in the gel by addition of 30 fjiL of dithiothreitol solution (7.7 mg/mL in 40% sacharose) in each slot (reduc tion of samples before electrophoresis leads to overlap of type I and III collagens). After another 90 minutes at 400 V, the gels were dried and analyzed with a PhosphorImager (Molecular Dynamics, Sunny Valley, CA). The sig nals from the radioactively labeled collagen chains were quantified in arbitrary but linear units using a PhosphorImager.20 The ratio of type IH/type I collagen, defined as the al(III)/[al(I) 4-a2(I) + al(III)] ratio, was then com puted. In all subjects, the final ratios are the average re-A suits of three independent separate labeling experiments.
All collagen determinations were done within four pas sages of the biopsy.
A ll type Ill/type I collagen ratios encountered in the control group were considered to represent normal values. As a result, all values found in the patient group that were below the lowest value of the control group were consid ered to represent abnormally low type III/type I ratios. In patients with abnormally low ratios of type IH/type I colla gen, intracellular type I I I procollagen was assessed by electrophoretic analysis of the content of lysed cells. Struc turally abnormal type I I I procollagen has an abnormal electrophoretic mobility.24
In the statistical analyses, Fisher's exact test and Wilcoxon rank sum test were used. R e s u lts. Most patients (38/41) presented with a rup tured intracranial aneurysm. In all patients except one, a cerebral angiography was performed. This patient was op erated on immediately because of a rapid clinical deterio ration, and the presence of an aneurysm was confirmed. In the three patients without presenting subarachnoid hem orrhage, the indications for a cerebral angiography were intracerebral hemorrhage, atypical facial pain w ith a posi tive family history for intracranial hemorrhages, and head ache with transient neurologic signs of visual disturbance and dysarthria. In this patient, brain CT showed a lesion compatible w ith an intracranial aneurysm. The median age of the patients was 49 years (ranging from 26 to 79 years). Other characteristics of the patients are shown in table 1. The three patients with a positive family history for polycystic kidney disease also had a positive family history for hypertension. Cerebral angiography in one pa tient also showed a small arteriovenous malformation. The median age of the control subjects was 43 years (ranging from 26 to 56 years), and there were 16 men and 25 women.
The results of the protein analysis are presented in figure 1. The type Ill/type I collagen ratios in the control subjects ranged from 5.5 to 19.8%, with a median of 10%. The resulting cutoff value below which type IH/type I col lagen ratios w ill be considered abnormally low was 5.5%. The type IH/type I collagen ratios in the patients ranged from 1.1 to 25.1%, with a median of 10.5%, and eight patients (19.5%) had a very low (<5.5%) ratio (figure 2). This difference is statistically significant (p = 0.005, Fish er's exact test). The ratios of the type Ill/type I collagen in patients and control subjects were compared on a group level and there was no evidence that the samples of the ratios of the patients and control subjects were derived from different distributions (two-tailed p = 0.51, Wilcoxon rank sum test).
The patient w ith the small arteriovenous malformation had a normal type Ill/type I collagen ratio. In fibroblasts from the eight patients w ith type Ill/type I collagen ratios of less than 5.5%, intracellular type I I I pro collagen was found to be low, and there were no indications of an excess of structurally abnormal type I I I procollagen.
We examined whether patients w ith a very low type Ill/type I collagen ratio (<5.5%) differed in clinical charac teristics from the patients w ith a normal type Ill/type I collagen ratio (table 2) . Apart from a trend favoring pa tients with a very low type Ill/type I collagen ratio to have a positive fam ily history for polycystic kidney disease, no statistically significant differences were found. Discussion* We examined a possible relationship between intracranial aneurysms and a reduced pro duction of type III collagen through protein analysis. We found no difference in the median type Ill/type I collagen ratios between patients and control sub jects. However, we found significantly more persons with low type Ill/type I collagen ratios in the patient group than in the control group. This is in keeping with the a priori formulated hypothesis. We exam ined the clinical characteristics of patients with nor mal and low type Ill/type I collagen ratios and found no differences. Using protein analysis, Leblanc et al.215,26 found normal type III collagen production in five patients with familial intracranial aneurysms of different families. However, there are several reports finding a reduced production of type III collagen in fibro blasts or low amounts of collagen type III in arterial wall samples of patients with intracranial aneurysms.16*21 Neil-Dwyer et al.16 studied a small population. Carboxymethyl cellulose chromatogra phy was performed in four control subjects and in seven patients, and gel scanning was used in four control subjects and seven patients. They concluded that 11 of 17 patients were type III collagen defi cient. 0stergaard and Oxlun17 used postmortem sam ples of the middle cerebral and brachial arteries of 1548 NEUROLOGY 49 December 1997 COl. Ill %
Figure I. Type I I I ¡type I collagen ratios (coL I I I %) in 41 control subjects (c) and 41 consecutive patients with intra cranial aneurysms (p aneurysm.).
14 patients who died of a ruptured intracranial an eurysm and similar samples of a control group of 14 patients who died of causes unrelated to aneurysm rupture. Electrophoresis and spectrophotometry re vealed a reduced amount of type I I I collagen in sam ples of the middle cerebral arteries in six patients of the ruptured aneurysm group and in none of the control group. However, the studied population was biased because only deceased patients were included, There was a difference between the type IH/type I collagen ratios determined from the middle cerebral artery and the brachial artery taken from the same patient. The authors did not supply explanation for this disparity. Majamaa et al.18 determined the syn thesis of type III collagen in skin fibroblast cultures from 11 patients with an intracranial aneurysm (plus 9 control subjects) and found no reduced pro- duction of type I I I collagen, although they reported a production of unstable type I I I collagen in 2 patients. In this study, six patients had a first-or seconddegree relative with an intracranial aneurysm, in cluding the two patients w ith unstable type I I I collagen production. In another study by Majamaa et al.19 in 12 patients with aneurysmal subarachnoid hemorrhages (plus 8 control subjects), protein analy sis showed combined procollagen production in two cell lines to be reduced. Despite widely varying methodology and several possible flaws in design and conduct, these studies indicated a role of re duced production of type I I I collagen in the forma tion of intracranial aneurysms.
T a b le 2 Characteristics o f patients w ith intracranial aneurysms and normal type III/type I collagen ratios compared with patients with low (<5.5%) type III/type I collagen ratios
Two patients w ith a low type Ill/type I collagen ratio (<5.5%) from our study also had a positive family history of polycystic kidney disease, and one had polycystic kidney disease. A dult polycystic kidney disease (ADPKD) is a disease w ith a firmly established association w ith in tracran ia l aneu rysms.27'29 Two loci for ADPKD are known and have previously been mapped (P K D 1 on chromosome 16 and P K D 2 on chromosome 4).30-31 A t least a third locus for ADPKD is still unmapped.32 The gene for type I I I collagen is located on chromosome 2.33 A genetic relation between ADPKD and EDS type IV is possible.
Five of eight patients w ith a low type I I I collagen had one or more risk factors for intracranial aneu rysms. This is in keeping w ith the theory that in tra cranial aneurysms have a multifactorial cause. This theory is based on the following clinical and epidemi ologic data. Independent acquired risk factors for in tracranial aneurysms are smoking, hypertension, and age.7-9 I f twins have intracranial aneurysms, they often occur in analogous or mirrored locations. 34 Fam ilial aggregation of intracranial aneurysms has been described on several occasions. First-degree rel atives of patients w ith an intracranial aneurysm in particular have a two-to threefold increased chance of harboring an aneurysm.35,36 Fam ilial aneurysms have characteristics different from those that occur spontaneously. They occur at a lower age, are located less often in the anterior cerebral artery ramifica tions, and may rupture at a smaller size. Among family members, aneurysms arise more often from the same arterial distribution and rupture more of ten w ithin the same decade of life.37,38 However, in d i cations exist for genetic heterogeneity. In a recent review on the pattern of inheritance in all published families, no single genetic mode could be identified. 39 Other links to the genetic nature of intracranial an eurysms are the abovementioned association with ADPKD and w ith heritable connective tissue disorders.27 '29,40 Intracranial aneurysms occur in the setting of pseudoxanthoma elasticum, osteogenesis imperfecta, Ehlers-Danlos syndrome type IV, and neurofibromatosis type 1. The suggestion of Adam son et al.41 on atherosclerosis being a single cause seems less likely.
Our determinations of collagen production in cell cultures will give a rough indication of the various processes happening in the arterial walls. However, our data suggest th a t a defect in the production of type I I I collagen plays a role in the pathogenesis of intracranial aneurysms. Although the reduced type Ill/type I collagen ratios are likely related to type I II collagen deficiency, we have not demonstrated this. 
